Kidney-limited AL amyloidosis: a case report and review of the literature

被引:0
作者
Velayati, Sara [1 ]
Belkin, Alexander [1 ]
Sidhu Kumar, Gurwinder [1 ]
Tharayil, Zubin J. [1 ]
Kumar, Neeru [2 ]
Patel, Samir [3 ]
机构
[1] Long Isl Community Hosp, Dept Internal Med, 101 Hosp Rd, Patchogue, NY 11772 USA
[2] Brookhaven Nephrol Associates PC, Dept Nephrol, Patchogue, NY USA
[3] Dept Hematol Oncol Canc & Blood Specialists, Patchogue, NY USA
来源
JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES | 2021年 / 11卷 / 05期
关键词
amyloidosis; AL amyloidosis; nephrotic syndrome; renal amyloidosis;
D O I
10.1080/20009666.2021.1942624
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amyloidosis involves the deposition of abnormal proteins in various tissues and results in progressive organ dysfunction, commonly affecting multiple organs. Two types of systemic amyloidosis are AA and AL; the former is associated with acute phase reactions and the latter is composed of light chain immunoglobulins. This disease commonly affects the kidneys and is evidenced by massive proteinuria. A biopsy is the gold standard of diagnosis, with Congo Red staining revealing an apple-green birefringence under polarized light. Although the kidneys are frequently affected in this disease, it is rare that amyloidosis is limited to the kidneys without involvement of other organs. We present an 83-year-old female with bilateral lower extremity swelling for several months who was found to have 12.374 grams of protein in a 24-hour urine sample and a large amount of free lambda chains. A renal biopsy demonstrated renal amyloidosis of the AL type. Serum immunofixation and flow cytometry were unremarkable for any plasma dyscrasia; a bone marrow biopsy did not reveal systemic amyloidosis and imaging with PET/CT scan did not show evidence of other organ involvement. She was diagnosed with renal-limited amyloidosis and started on bortezomib, melphalan, and steroids. Clinicians should be aware of the signs and symptoms of amyloidosis, specifically its ability to present with unusual involvement of individual organs.
引用
收藏
页码:698 / 702
页数:5
相关论文
共 10 条
  • [1] Primary Localized Amyloidosis of the Intestine: A Pathologist Viewpoint
    Alshehri, Saeed Ali
    Hussein, Mahmoud Rezk Abdelwahed
    [J]. GASTROENTEROLOGY RESEARCH, 2020, 13 (04) : 129 - 137
  • [2] Guidelines on the diagnosis and management of AL amyloidosis
    Bird, J
    Cavenagh, J
    Hawkins, P
    Lachmann, H
    Mehta, A
    Samson, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (06) : 681 - 700
  • [3] Comparison of amyloid deposition in human kidney biopsies as predictor of poor patient outcome
    Castano, Ekaterina
    Palmer, Matthew B.
    Vigneault, Christine
    Luciano, Randy
    Wong, Serena
    Moeckel, Gilbert
    [J]. BMC NEPHROLOGY, 2015, 16
  • [4] Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management
    Fotiou, Despina
    Dimopoulos, Meletios Athanasios
    Kastritis, Efstathios
    [J]. HEMASPHERE, 2020, 4 (04):
  • [5] Renal-limited AL amyloidosis - a diagnostic and management dilemma
    Fuah, Kar Wah
    Lim, Christopher Thiam Seong
    [J]. BMC NEPHROLOGY, 2018, 19
  • [6] Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment
    Gertz, Morie A.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : 1169 - 1180
  • [7] AL amyloidosis: from molecular mechanisms to targeted therapies
    Merlini, Giampaolo
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 1 - 12
  • [8] National Comprehensive Cancer Network, 2021, SYSTEMIC LIGHT CHAIN
  • [9] Systemic AA amyloidosis: epidemiology, diagnosis, and management
    Real de Asua, Diego
    Costa, Ramon
    Maria Galvan, Jose
    Teresa Filigheddu, Maria
    Trujillo, Davinia
    Cadinanos, Julen
    [J]. CLINICAL EPIDEMIOLOGY, 2014, 6 : 369 - 377
  • [10] AL amyloidosis: advances in diagnostics and treatment
    Rysava, Romana
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (09) : 1460 - +